home / stock / agtc / agtc news


AGTC News and Press, Applied Genetic Technologies Corporation From 09/27/19

Stock Information

Company Name: Applied Genetic Technologies Corporation
Stock Symbol: AGTC
Market: NASDAQ
Website: agtc.com

Menu

AGTC AGTC Quote AGTC Short AGTC News AGTC Articles AGTC Message Board
Get AGTC Alerts

News, Short Squeeze, Breakout and More Instantly...

AGTC - Thin ranks in premarket gainers

The9 (NASDAQ: NCTY ) +34%  on selling several subsidiaries to Kapler. More news on: The9 Limited, LATAM Airlines Group S.A., Applied Genetic Technologies Corporation, Stocks on the move, Read more ...

AGTC - Goldman sees 38% upside in Seattle Genetics in premarket analyst action

Arcus Biosciences (NYSE: RCUS ) initiated with Buy rating and $22 (150% upside) price target at Mizuho Securities. More news on: Arcus Biosciences, Inc., Stealth BioTherapeutics Corp, HOOKIPA Pharma Inc., Healthcare stocks news, Stocks on the move, , Read more ...

AGTC - Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q4 2019 Results - Earnings Call Transcript

Applied Genetic Technologies Corporation (NASDAQ:AGTC) Q4 2019 Earnings Conference Call September 26, 2019 4:30 PM ET Company Participants Sue Washer - Chief Executive Officer Bill Sullivan - Chief Financial Officer Mark Shearman - Chief Scientific Officer Theresa Heah - Chi...

AGTC - Applied Genetic Technologies Corporation 2019 Q4 - Results - Earnings Call Slides

The following slide deck was published by Applied Genetic Technologies Corporation in conjunction with their 2019 Q4 earnings Read more ...

AGTC - Applied Genetic EPS misses by $0.04, misses on revenue

Applied Genetic (NASDAQ: AGTC ): Q4 GAAP EPS of -$0.58 misses by $0.04 . More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

AGTC - AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal Year Ended June 30, 2019

Company announces promising topline six-month dose escalation data from its ongoing Phase 1/2 clinical trials for X-linked retinitis pigmentosa (XLRP) Preliminary three-month XLRP dose expansion data demonstrates improvement in 50% of centrally dosed patients Early data from both ...

AGTC - AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 26, 2019

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announ...

AGTC - AGTC to Present at Upcoming Conferences

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announce...

AGTC - Italian Achromatopsia Association Increases Global Awareness of Achromatopsia, a Rare Genetic Eye Disease, With an Expedition to Pingelap, the Island of the Color Blind

TRENTO, Italy, Aug. 14, 2019 (GLOBE NEWSWIRE) -- The Italian Achromatopsia Association (IAA) today announced that it is organizing a trip to Pingelap, a remote Micronesian atoll in the South Pacific, also known as the “Island of the Color Blind . ” While the incidence of achro...

AGTC - AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 14, 2019

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

Previous 10 Next 10